This was associated with the increased proliferation of CD8+ TILs and decreased Treg levels in the TME and featured a significant reduction in tumour growth compared to vaccine administered without TGF-β silencing in murine models of melanoma [196]. The gene discussed is CD8A; the disease is neoplasm.